Self-administered methotrexate autoinjector confers high usability

11:31 EDT 20 Mar 2017 | Healio

A new self-administered methotrexate autoinjector had 90.5% subject usability, according to recently published data. Christophe Hudry, MD, of the rheumatology department at Cochin Hospital in Paris, and colleagues conducted a study of 42 participants, which consisted of rheumatology nurses and patients with rheumatoid arthritis, who were divided into two groups according to hand disability. Each participant performed three injections with a water-filled device on a foam pad. The first injection — which the researchers defined as the first phase — was made after reading the instructions for use. The second phase comprised two injections made after explanations to the participant when in an optimum environment and then in a home environment. Researchers assessed auto-injector usability by questionnaire, with success defined as at least 75% positive response, and a score card of injection performance, with success defined as correct execution of at least 75% of steps.

Original Article: Self-administered methotrexate autoinjector confers high usability


More From BioPortfolio on "Self-administered methotrexate autoinjector confers high usability"

Quick Search

Relevant Topics

Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...